Published in Antiviral Res on February 25, 2010
Rabies, still neglected after 125 years of vaccination. PLoS Negl Trop Dis (2010) 1.36
Discovery of novel rhabdoviruses in the blood of healthy individuals from West Africa. PLoS Negl Trop Dis (2015) 0.91
Characterization of the interactions between the nucleoprotein and the phosphoprotein of Henipavirus. J Biol Chem (2011) 0.82
Focal adhesion kinase is involved in rabies virus infection through its interaction with viral phosphoprotein P. J Virol (2014) 0.81
Oncolytic vesicular stomatitis virus and bortezomib are antagonistic against myeloma cells in vitro but have additive anti-myeloma activity in vivo. Exp Hematol (2013) 0.81
A bioinformatics approach to the structure, function, and evolution of the nucleoprotein of the order mononegavirales. PLoS One (2011) 0.80
Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV. Cancer Gene Ther (2013) 0.79
Nuclear Trafficking of the Rabies Virus Interferon Antagonist P-Protein Is Regulated by an Importin-Binding Nuclear Localization Sequence in the C-Terminal Domain. PLoS One (2016) 0.76
Structure of the C-terminal domain of lettuce necrotic yellows virus phosphoprotein. J Virol (2013) 0.76
Putative domain-domain interactions in the vesicular stomatitis virus L polymerase protein appendage region. J Virol (2014) 0.75
Turbot (Scophthalmus maximus) vs. VHSV (Viral Hemorrhagic Septicemia Virus): A Review. Front Physiol (2016) 0.75
ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics (1999) 21.85
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med (1997) 17.51
The atomic structure of the bluetongue virus core. Nature (1998) 4.27
A mechanism for initiating RNA-dependent RNA polymerization. Nature (2001) 3.99
Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6 A. J Mol Biol (1979) 3.88
Genetic polymorphism in the rabies virus nucleoprotein gene. Virology (1995) 3.43
Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J Virol (1996) 3.12
Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus. J Acquir Immune Defic Syndr (1990) 2.90
Crystal structure at 2.8 A resolution of a soluble form of the cell adhesion molecule CD2. Nature (1992) 2.76
The enterotoxin gene (cpe) of Clostridium perfringens can be chromosomal or plasmid-borne. Mol Microbiol (1995) 2.71
A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group. N Engl J Med (1995) 2.66
Structure of tumour necrosis factor. Nature (1989) 2.62
Crystal structure of SIV matrix antigen and implications for virus assembly. Nature (1995) 2.59
First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality! Clin Microbiol Infect (2010) 2.53
Angiogenesis: regulators and clinical applications. Biochem Pharmacol (2001) 2.47
Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. Nature (1997) 2.41
Structure and dimerization of a soluble form of B7-1. Immunity (2000) 2.33
Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors. J Med Chem (1996) 2.29
The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J (1999) 2.28
The privacy paradox: laying Orwell's ghost to rest. CMAJ (2001) 2.22
Cloning, mapping, and molecular characterization of the rRNA operons of Clostridium perfringens. J Bacteriol (1991) 2.18
Structural changes in glycogen phosphorylase induced by phosphorylation. Nature (1988) 2.16
The smaller human VH gene families display remarkably little polymorphism. EMBO J (1989) 2.15
The crystal structure of plasma gelsolin: implications for actin severing, capping, and nucleation. Cell (1997) 2.10
Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus. J Virol (1998) 2.09
A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance. Antimicrob Agents Chemother (1999) 2.08
Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation. Nat Struct Biol (1999) 1.88
Tick histamine-binding proteins: isolation, cloning, and three-dimensional structure. Mol Cell (1999) 1.88
PCR technique as an alternative method for diagnosis and molecular epidemiology of rabies virus. Mol Cell Probes (1991) 1.87
Evolution of European bat lyssaviruses. J Gen Virol (1997) 1.86
Crystal structure of a heparin- and integrin-binding segment of human fibronectin. EMBO J (1999) 1.84
The highly ordered double-stranded RNA genome of bluetongue virus revealed by crystallography. Cell (1999) 1.84
Human heavy-chain variable region gene family nonrandomly rearranged in familial chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (1987) 1.76
Crystal structure of a purple acid phosphatase containing a dinuclear Fe(III)-Zn(II) active site. Science (1995) 1.72
Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1. Nature (1994) 1.67
Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro. J Virol (1997) 1.65
Recombinant protein expression and solubility screening in Escherichia coli: a comparative study. Acta Crystallogr D Biol Crystallogr (2006) 1.65
Alpha-(1-3)- and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro. Antimicrob Agents Chemother (1991) 1.63
Management of fibular hemimelia: amputation or limb lengthening. J Bone Joint Surg Br (1997) 1.63
Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase. Structure (2000) 1.60
Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors. Proc Natl Acad Sci U S A (2002) 1.60
Catalysis in the crystal: synchrotron radiation studies with glycogen phosphorylase b. EMBO J (1987) 1.60
Intravitam diagnosis of human rabies by PCR using saliva and cerebrospinal fluid. J Clin Microbiol (1998) 1.59
Clinically silent rabies infection in (zoo) bats. Vet Rec (1998) 1.58
The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology. Tuberculosis (Edinb) (2003) 1.55
Crystal structure of an integrin-binding fragment of vascular cell adhesion molecule-1 at 1.8 A resolution. Nature (1995) 1.55
Unique features in the structure of the complex between HIV-1 reverse transcriptase and the bis(heteroaryl)piperazine (BHAP) U-90152 explain resistance mutations for this nonnucleoside inhibitor. Proc Natl Acad Sci U S A (1997) 1.55
A novel secreted cyclophilin-like protein (SCYLP). J Biol Chem (1991) 1.52
Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties. J Biol Chem (1999) 1.50
High-throughput sample handling and data collection at synchrotrons: embedding the ESRF into the high-throughput gene-to-structure pipeline. Acta Crystallogr D Biol Crystallogr (2006) 1.50
Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5 A resolution. Structure (1994) 1.44
Crystal structure of the extracellular region of human tissue factor. Nature (1994) 1.43
Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors. J Mol Biol (2001) 1.42
Fetal intervention for severe lower urinary tract obstruction: a multicenter case-control study comparing fetal cystoscopy with vesicoamniotic shunting. Ultrasound Obstet Gynecol (2015) 1.41
The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group. JAMA (1994) 1.41
Fighting rabies in Africa: the Africa Rabies Expert Bureau (AfroREB). Vaccine (2008) 1.41
Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood (2001) 1.39
Primary structure of the human, membrane-associated Ca2+-binding protein p68 a novel member of a protein family. EMBO J (1988) 1.38
Evidence for the role of His-142 of protein 1C in the acid-induced disassembly of foot-and-mouth disease virus capsids. J Gen Virol (1999) 1.38
An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity (1996) 1.38
Refined structure of baboon alpha-lactalbumin at 1.7 A resolution. Comparison with C-type lysozyme. J Mol Biol (1989) 1.38
Design of MKC-442 (emivirine) analogues with improved activity against drug-resistant HIV mutants. J Med Chem (1999) 1.36
Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. J Exp Med (1996) 1.36
Translocation portals for the substrates and products of a viral transcription complex: the bluetongue virus core. EMBO J (2001) 1.35
The structure of a cypovirus and the functional organization of dsRNA viruses. Nat Struct Biol (1999) 1.35
Egg fluids and cells of the chorioallantoic membrane of embryonated chicken eggs can select different variants of influenza A (H3N2) viruses. Virology (1995) 1.35
Signaling lymphocytic activation molecule (CDw150) is homophilic but self-associates with very low affinity. J Biol Chem (2000) 1.34
Episodic evolution of pyrin in primates: human mutations recapitulate ancestral amino acid states. Nat Genet (2001) 1.33
The impact of protein characterization in structural proteomics. Acta Crystallogr D Biol Crystallogr (2006) 1.32
Perspectives for the treatment of infections with Flaviviridae. Clin Microbiol Rev (2000) 1.30
Molecular epidemiology of rabies virus in France: comparison with vaccine strains. J Gen Virol (1992) 1.30
The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding. Cell (1994) 1.29
The human low affinity Fcgamma receptors IIa, IIb, and III bind IgG with fast kinetics and distinct thermodynamic properties. J Biol Chem (2001) 1.28
Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity (1996) 1.27
Poly(I)-poly(C12U) but not ribavirin prevents death in a hamster model of Nipah virus infection. Antimicrob Agents Chemother (2006) 1.27
Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids. J Virol (1995) 1.27
Crystal structure of a berenil-dodecanucleotide complex: the role of water in sequence-specific ligand binding. EMBO J (1990) 1.26
Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. Mol Cell (1998) 1.25
Localization of the cellular-fibronectin-specific epitope recognized by the monoclonal antibody IST-9 using fusion proteins expressed in E. coli. FEBS Lett (1987) 1.24
Improved tumor targeting with chemically cross-linked recombinant antibody fragments. Cancer Res (1994) 1.24
Antiviral agents acting as DNA or RNA chain terminators. Handb Exp Pharmacol (2009) 1.23
Continuous and discontinuous changes in the unit cell of HIV-1 reverse transcriptase crystals on dehydration. Acta Crystallogr D Biol Crystallogr (1998) 1.22
Activity and specificity of human aldolases. J Mol Biol (1991) 1.21
Expression of soluble recombinant glycoproteins with predefined glycosylation: application to the crystallization of the T-cell glycoprotein CD2. Protein Eng (1993) 1.21
Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8alphaalpha. J Biol Chem (2000) 1.21
An atomic model of the outer layer of the bluetongue virus core derived from X-ray crystallography and electron cryomicroscopy. Structure (1997) 1.21
Structure of the complex of an Fab fragment of a neutralizing antibody with foot-and-mouth disease virus: positioning of a highly mobile antigenic loop. EMBO J (1997) 1.20
Structure of the brain-derived neurotrophic factor/neurotrophin 3 heterodimer. Biochemistry (1995) 1.20
Crystal structure of human alpha-lactalbumin at 1.7 A resolution. J Mol Biol (1991) 1.20
Mechanism-based suppression of dideoxynucleotide resistance by K65R human immunodeficiency virus reverse transcriptase using an alpha-boranophosphate nucleoside analogue. J Biol Chem (2001) 1.20
Favipiravir (T-705) inhibits in vitro norovirus replication. Biochem Biophys Res Commun (2012) 1.20
Determination of the affinity and kinetic constants for the interaction between the human virus echovirus 11 and its cellular receptor, CD55. J Biol Chem (1998) 1.19